Back

Vaginal Lactobacillus fatty acid response mechanisms reveal a novel strategy for bacterial vaginosis treatment

Zhu, M.; Frank, M. W.; Radka, C. D.; Jeanfavre, S.; Tse, M. W.; Avila Pacheco, J.; Pierce, K.; Deik, A.; Xhu, J.; Hussain, S.; Hussain, F. A.; Xulu, N.; Khan, N.; Pillay, V.; Dong, K. L.; Ndung'u, T.; Clish, C. B.; Rock, C. O.; Blainey, P. C.; Bloom, S. M.; Kwon, D. S.

2023-12-30 microbiology
10.1101/2023.12.30.573720 bioRxiv
Show abstract

Bacterial vaginosis (BV), a common syndrome characterized by Lactobacillus-deficient vaginal microbiota, is associated with adverse health outcomes. BV often recurs after standard antibiotic therapy in part because antibiotics promote microbiota dominance by Lactobacillus iners instead of Lactobacillus crispatus, which has more beneficial health associations. Strategies to promote L. crispatus and inhibit L. iners are thus needed. We show that oleic acid (OA) and similar long-chain fatty acids simultaneously inhibit L. iners and enhance L. crispatus growth. These phenotypes require OA-inducible genes conserved in L. crispatus and related species, including an oleate hydratase (ohyA) and putative fatty acid efflux pump (farE). FarE mediates OA resistance, while OhyA is robustly active in the human vaginal microbiota and sequesters OA in a derivative form that only ohyA-harboring organisms can exploit. Finally, OA promotes L. crispatus dominance more effectively than antibiotics in an in vitro model of BV, suggesting a novel approach for treatment.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.